Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LanzaJet has successfully commercialized the world's first ethanol-to-Sustainable Aviation Fuel (SAF) technology, with initial transatlantic and transpacific SAF-powered flights, and has opened its first commercial plant, Freedom Pines Fuels, capable of producing 10 million gallons per year of SAF and renewable diesel from low carbon ethanol
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LanzaJet.